IN response to the recent vaccine scandal, Shenzhen-based biotech firm BioKangtai released a statement Sunday afternoon saying that no adverse reactions have been caused by its vaccines, the Southern Metropolis Daily reported yesterday.

The company said that there are a number of untrue statements about BioKangtai in an online article that questions the domestic vaccine industry on the basis of the forged production records of a certain vaccine company.

In the statement, BioKangtai disclaimed any equity relations and business contacts with other vaccine companies. The article has since been deleted from the WeChat platform, but it is still being forwarded by some media and has caused public misunderstanding, said the company.

Additionally, it stated that the company has produced more than 1 billion doses of hepatitis B vaccines. More than 300 million people have been inoculated and no unwelcome reactions have occurred.

The safety and efficacy of domestic vaccines have been recognized by the World Health Organization (WHO), and the quality of domestic vaccines has reached international standards, BioKangtai said in the statement.

Back in 2013, BioKangtai was entangled in a vaccine scare. The company said it had elaborated the incident in its listing prospectus responding to the untrue reports of some media.

In January 2014, the national food and drug administration and the health and family planning commission jointly issued the results of an investigation into BioKangtai and said no quality problems had been found in the hepatitis B vaccines produced by the company.

(Zhang Yu)